Biomerieux SA Price, Chart & Factor Exposure
Free Data & Analytics AccessNext earnings: Fri, Feb 26, 2027, after the market closes · estimates and history
Biomerieux SA Forecast
Biomerieux SA short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 19.9% a year, a typical one-standard-deviation range is 87.87–92.93 over a week, 85.22–95.58 over a month and 72.45–108.35 over a year. (Signals as of 5 Nov 2026.)
Biomerieux SA Price Chart
Biomerieux SA Factors
YoY −20.1%
YoY −16.6%
YoY −23.5%
YoY −20.4%
YoY −19.2%
YoY +25.1%
YoY −16.4%
YoY −287.4%
YoY −284.3%
YoY +1.6%
YoY +10.8%
YoY −23.7%
YoY —
YoY −11.8%
Biomerieux SA fundamentals: income statement, balance sheet & cash flow
Biomerieux SA reported revenue of €4.07bn and net income of €397.5m in FY2025, the year ended 31 December 2025 — revenue up 2.3% and net income down 8.0% on the prior year. Free cash flow was €453.0m. These figures are as reported in the filings, not restated: 21 fiscal years and 74 quarters of history, back to December 2005.
| EUR millions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 4,069.8 | 3,979.9 | 3,674.7 | 3,589.1 | 3,376.2 |
| Cost of revenue | 1,927.8 | 1,764.6 | 1,617.4 | 1,628.0 | 1,406.8 |
| Gross profit | 2,142.0 | 2,215.3 | 2,057.3 | 1,961.1 | 1,969.4 |
| Research & development | 507.4 | 491.5 | 460.1 | 446.6 | 385.8 |
| Selling, general & admin. | 1,073.4 | 1,135.0 | 1,156.6 | 954.7 | 815.6 |
| Operating income | 561.2 | 588.8 | 439.1 | 559.8 | 768.0 |
| EBITDA | 999.6 | 897.5 | 701.3 | 811.9 | 977.8 |
| Interest expense | 15.8 | 16.0 | 4.4 | 4.1 | 9.1 |
| Pre-tax income | 525.5 | 579.3 | 437.5 | 550.2 | 748.3 |
| Income tax | 128.8 | 154.3 | 114.5 | 109.7 | 149.4 |
| Net income | 397.5 | 432.2 | 357.6 | 452.4 | 601.1 |
Download Biomerieux SA fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.BIM.PA&statement=all&freq=a&format=csv&years=10
Figures in EUR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.
Research on Biomerieux SA
Explore MacroFinance macro & markets research and analysis.
Biomerieux SA Trading Strategies
9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Biomerieux SA; 1 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in VGK | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Adaptive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Defensive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Protective Asset Allocation - CPR | Moderate | Monthly | Premium · upgrade to view | |||
| Financial Mentor's Optimum3 | Moderate | Monthly | Premium · upgrade to view | |||
| Wouter Keller's Bold Asset Allocation - Balanced | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Protective Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Vigilant Asset Allocation - Balanced | Moderate | Monthly | Premium · upgrade to view | |||
| Ilya Kipnis' Defensive Adaptive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keuning and Keller's Generalized Protective Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Biomerieux SA’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Biomerieux SA (France)
Biomerieux SA is a listed security in France. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on BIMobject AB
Frequently asked questions
What is Biomerieux SA?
What is the latest Biomerieux SA price?
Is Biomerieux SA in an uptrend?
How volatile is Biomerieux SA?
What factors affect Biomerieux SA?
Which trading strategies trade Biomerieux SA?
How are Biomerieux SA returns analysed?
Where can I download free Biomerieux SA historical data?
Free Biomerieux SA historical data (last 10 years)
Browse or instantly download the last 10 years of Biomerieux SA daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.BIM.PA&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 91.3 |
| 2026-11-19 | 91.15 |
| 2026-11-18 | 90.75 |
| 2026-11-17 | 90.65 |
| 2026-11-16 | 91.9 |
| 2026-11-13 | 92.8 |
| 2026-11-12 | 92.3 |
| 2026-11-11 | 92.2 |
| 2026-11-10 | 91.65 |
| 2026-11-09 | 91.3 |
About this stock
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL, a rapid AST system; ETEST, a gradient method on culture media; BIOMERIEUX EPISEQ CS, a whole genome sequencing solution for epidemiologic monitoring; VIDAS, a specific marker of severe bacterial infections/sepsis; and Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making. It also provides culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration of antibiotic; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. The company was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. operates as a subsidiary of Institut Mérieux SA.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.